Looking to the future: research designs for study of headache disease progression

Headache
Richard B Lipton, Marcelo E Bigal

Abstract

Evidence from clinical observation and population studies suggests that migraine sometimes transforms into chronic migraine. Risk factors for progression include headache frequency, obesity, snoring, stressful life events, and head injury. Other candidate risk factors include depression, anxiety, and lifestyle factors. Progression in a subgroup only raises the possibility that risk factor management or other forms of treatment may prevent migraine progression. Herein, we consider the design of clinical trials for interventions which could prevent the transformation of migraine to chronic migraine. We recommend enrolling individuals at high risk for progression based on baseline high headache frequency, delivering intervention in the context of a double-blind randomized trial and assessing either the onset of chronic migraine or major change in headache frequency as outcomes.

References

Oct 15, 1992·The New England Journal of Medicine·K SilvermanR R Griffiths
Jun 1, 1990·Archives of Internal Medicine·M S Aldrich, J B Chauncey
Feb 1, 1987·Headache·N T MathewF Perez
Nov 1, 1982·Headache·J R Saper
Feb 1, 1994·Journal of Epidemiology and Community Health·H G Nijhuis, L J van der Maesen
Jan 1, 1996·Alzheimer Disease and Associated Disorders·P Leber
Feb 5, 1998·JAMA : the Journal of the American Medical Association·A R Jadad, D Rennie
Feb 13, 2001·Cephalalgia : an International Journal of Headache·P Tfelt-HansenUNKNOWN International Headache Society Clinical Trials Subcommittee
Jan 25, 2002·The New England Journal of Medicine·Peter J GoadsbyMichel D Ferrari
Jan 17, 2003·Statistics in Medicine·Jong-Hyeon JeongSamuel Wieand
Jan 30, 2004·JAMA : the Journal of the American Medical Association·Mark C KruitLenore J Launer
Feb 27, 2004·Cephalalgia : an International Journal of Headache·A V Krymchantowski, P F Moreira
May 6, 2004·JAMA : the Journal of the American Medical Association·Osama O Zaidat
May 25, 2004·Cephalalgia : an International Journal of Headache·M E BigalR B Lipton
Jul 1, 2004·Drug and Alcohol Dependence·Stephanie T LanzaRobert L Balster
Dec 23, 2004·Headache·A I ScherR B Lipton
Apr 19, 2005·Headache·Richard B Lipton, Marcelo E Bigal
Jun 1, 2005·Headache·Donald B PenzienUNKNOWN American Headache Society Behavioral Clinical Trials Workgroup
Nov 5, 2005·BMJ : British Medical Journal·Robert J ParkerClare Jeffries
Dec 16, 2005·Neurology·Marcelo E BigalRichard B Lipton
Jan 24, 2006·Lancet Neurology·Sheryl R HautRichard B Lipton
Mar 15, 2006·Expert Review of Neurotherapeutics·Marcelo E Bigal, Richard B Lipton
Jul 20, 2006·JAMA : the Journal of the American Medical Association·Tobias KurthJulie E Buring
Jul 26, 2006·Neurology·Marcelo E Bigal, Richard B Lipton
Oct 17, 2006·Headache·Marcelo E Bigal, Richard B Lipton
Nov 23, 2006·Headache·Ninan T Mathew
Jan 30, 2007·Cephalalgia : an International Journal of Headache·T J SchwedtR S Zimmerman
Apr 20, 2007·Cephalalgia : an International Journal of Headache·H-C DienerUNKNOWN TOPMAT-MIG-201(TOP-CHROME) Study Group
Apr 25, 2007·Archives of Internal Medicine·Tobias KurthJulie E Buring

❮ Previous
Next ❯

Citations

Feb 21, 2009·Cephalalgia : an International Journal of Headache·S K Aurora
Sep 8, 2010·Cephalalgia : an International Journal of Headache·Min YangMark Kosinski
Oct 27, 2010·Cephalalgia : an International Journal of Headache·Richard B LiptonJoseph Hulihan
Jan 25, 2013·Journal of Clinical Neurology·Yong Seo KooKi-Young Jung
Dec 28, 2018·Headache·Dawn C BuseRichard B Lipton
Jan 30, 2009·Headache·Richard B Lipton, Fred D Sheftell
Jul 10, 2009·Current Pain and Headache Reports·Todd A SmithermanDonald B Penzien
Aug 2, 2014·Health and Quality of Life Outcomes·Regina Rendas-BaumMark Kosinski
May 22, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·M Aguggia, M G Saracco
May 22, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria Gabriella SaraccoM Aguggia
Nov 11, 2010·Current Pain and Headache Reports·Aubrey N ManackRichard B Lipton
Jan 5, 2011·Current Pain and Headache Reports·Sheena K AuroraPatricia M Barrodale
Dec 25, 2013·PloS One·Aurelie MillierMondher Toumi
Nov 19, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A FavaD Bosco
May 7, 2009·Current Opinion in Neurology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
M Aguggia, M G Saracco
Hematology/oncology Clinics of North America
S B Green
© 2021 Meta ULC. All rights reserved